Business
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations
About this update from Sana Biotechnology, Inc.
[{"type":"image","alt":"Sana Biotechnology, Inc","displaySize":"","headline":null,"caption":"Sana Biotechnology, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/c8ec5ce7c1d4da77d92cdc607ff85c4e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PW1btp2owOxzuDhhLJX9Mw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c8ec5ce7c1d4da77d92cdc607ff85c4e","width":300,"height":85}},"lazy":false},{"type":"text","content":"SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.","length":447,"tagName":"p"},{"type":"text","content":"The webcast will be accessible on the Investor Relations page of Sana’s website at https://sana.com/. A replay of the presentation will be available at the same location for 30 days following the conference.","length":207,"tagName":"p"},{"type":"text","content":"About Sana BiotechnologySana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA. For more information about Sana Biotechnology, please visit https://sana.com/.","length":562,"tagName":"p"},{"type":"text","content":"Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements about Sana Biotechnology, Inc. (the “Company,” “we,” “us,” or “our”) within the meaning of the federal securities laws, including those related to the Company’s vision; the Company’s participation at the 44th Annual J.P. Morgan Healthcare Conference; and the subject matter of the Company’s presentation at the conference. All statements o...